Sutro Biopharma Inc. (STRO) names Hans-Peter Gerber as Chief Scientific Officer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ORCL
2. SPY
3. FLG
4. GMAB
5. ACCV
6. SPCX
7. AZN
8. APO
9. META
10. FICO

Go back to Sutro Biopharma Inc. (STRO) names Hans-Peter Gerber as Chief Scientific Officer

Sutro Biopharma Appoints Dr. Hans-Peter Gerber as Chief Scientific Officer

September 19, 2023 8:00 AM EDT

SOUTH SAN FRANCISCO, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced the appointment of Hans-Peter Gerber, Ph.D., as Chief Scientific Officer, effective September 18, 2023. Dr. Gerber brings over 25 years of drug discovery and development experience to Sutro, with extensive scientific background and expertise in ADCs, targeted oncology, and novel biotherapeutic platforms.

Dr. Gerbers deep experience in the development of ADCs and other novel therapeutics make him an invaluable addition to... More